Latest Stories
Bowhead Specialty (NYSE:BOW) Surprises With Q4 CY2025 Sales
Specialty insurance company Bowhead Specialty Holdings (NYSE:BOW) announced better-than-expected revenue in Q4 CY2025, with sales up 27.1% year on year to $151.7 million. Its GAAP profit of $0.44 per share was 2.2% below analysts’ consensus estimates.
Shoals (NASDAQ:SHLS) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops 10.8%
Solar energy systems company Shoals (NASDAQ:SHLS) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 38.6% year on year to $148.3 million. On top of that, next quarter’s revenue guidance ($130 million at the midpoint) was surprisingly good and 9.6% above what analysts were expecting. Its non-GAAP profit of $0.10 per share was 28.4% below analysts’ consensus estimates.
Armstrong World (NYSE:AWI) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Ceiling and wall solutions company Armstrong World Industries (NYSE:AWI) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.6% year on year to $388.3 million. On the other hand, the company’s full-year revenue guidance of $1.77 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.61 per share was 4% below analysts’ consensus estimates.
AdaptHealth (NASDAQ:AHCO) Surprises With Q4 CY2025 Sales
Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.2% year on year to $846.3 million. The company’s full-year revenue guidance of $3.48 billion at the midpoint came in 1% above analysts’ estimates. Its GAAP loss of $0.76 per share was significantly below analysts’ consensus estimates.
First Watch (NASDAQ:FWRG) Posts Q4 CY2025 Sales In Line With Estimates
Breakfast restaurant chain First Watch Restaurant Group (NASDAQ:FWRG) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 20.2% year on year to $316.4 million. Its GAAP profit of $0.24 per share was significantly above analysts’ consensus estimates.
Keurig Dr Pepper (NASDAQ:KDP) Exceeds Q4 CY2025 Expectations
Beverage company Keurig Dr Pepper (NASDAQ:KDP) announced better-than-expected revenue in Q4 CY2025, with sales up 10.5% year on year to $4.50 billion. Its non-GAAP profit of $0.60 per share was 1.9% above analysts’ consensus estimates.
Dillard's (NYSE:DDS) Misses Q4 CY2025 Sales Expectations
Department store chain Dillard’s (NYSE:DDS) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 3% year on year to $1.99 billion. Its GAAP profit of $13.05 per share was 13.5% above analysts’ consensus estimates.
CECO Environmental (NASDAQ:CECO) Exceeds Q4 CY2025 Expectations
Environmental solutions provider CECO Environmental (NASDAQ:CECO) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 35.4% year on year to $214.7 million. The company’s full-year revenue guidance of $950 million at the midpoint came in 8.1% above analysts’ estimates. Its GAAP profit of $0.08 per share was 73.9% below analysts’ consensus estimates.
Planet Fitness (NYSE:PLNT) Exceeds Q4 CY2025 Expectations But Stock Drops
Inclusive gym franchise company (NYSE:PLNT) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 10.5% year on year to $376.3 million. Its non-GAAP profit of $0.83 per share was 4.8% above analysts’ consensus estimates.
Elanco (NYSE:ELAN) Surprises With Q4 CY2025 Sales
Animal health company Elanco (NYSE:ELAN) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 12.2% year on year to $1.14 billion. Guidance for next quarter’s revenue was better than expected at $1.29 billion at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $0.13 per share was 15.6% above analysts’ consensus estimates.